← back to search

Mengji Lu

Shenzhen University · DE
Area of research
Epidemiology · Hepatology
Research interest
Research interests include Hepatitis B Virus Studies, Hepatitis C virus research, Liver Disease Diagnosis and Treatment, and Hepatitis Viruses Studies and Epidemiology.
h-index
60
citations
15,327
works
443
NIH funding
primary concept
Biology
email

Recent publications

Glutamine antagonist DON attenuates chikungunya virus-induced myositis by suppressing inflammatory activation in a murine model.
2026cited by 0position: contributordoi
ESCRT Machinery in HBV Life Cycle: Dual Roles in Autophagy and Membrane Dynamics for Viral Pathogenesis
Cells 2025cited by 7position: lastdoi
HBV and host metabolic crosstalk: Reprogramming pathways for viral replication and pathogenesis
Virologica Sinica 2025cited by 4position: contributordoi
ESCRT Machinery in HBV Life Cycle: Dual Roles in Autophagy and Membrane Dynamics for Viral Pathogenesis.
2025cited by 2position: contributordoi
Mitochondrial respiratory chain regulates HBV clearance through dual modulation of lysosomal acidification.
2025cited by 2position: contributordoi
Emerging plasticizer induced lipid metabolism disorders revealed by network toxicology molecular docking and dynamics simulation
Scientific Reports 2025cited by 2position: middledoi
Identification and prediction of isolated lateral meniscal lesions in the Chinese population using MRI-based anatomical parameters
Journal of Orthopaedic Surgery and Research 2025cited by 2position: middledoi
Trends and future burden of other musculoskeletal diseases in China (1990–2041): a comparative analysis with G20 countries using GBD data
BMC Public Health 2025cited by 2position: firstdoi
Assessment of drug induced hyperuricemia and gout risk using the FDA adverse event reporting system
Scientific Reports 2025cited by 2position: middledoi
Interleukin-6 classic and trans-signaling utilize glucose metabolism reprogramming to achieve anti- or pro-inflammatory effects
Metabolism 2024cited by 48position: middledoi
Deciphering lung granulomas in HIV & TB co-infection: unveiling macrophages aggregation with IL6R/STAT3 activation.
2024cited by 9position: contributordoi
Interconnection of cellular autophagy and endosomal vesicle trafficking and its role in hepatitis B virus replication and release
Virologica Sinica 2024cited by 8position: contributordoi
Macrophage migration inhibitory factor receptor CD74 expression is associated with expansion and differentiation of effector T cells in COVID-19 patients
Frontiers in Immunology 2023cited by 17position: middledoi
Nuclear translocation of YAP drives BMI-associated hepatocarcinogenesis in hepatitis B virus infection.
2023cited by 9position: contributordoi
Hepatitis B virus promotes its own replication by enhancing RAB5A-mediated dual activation of endosomal and autophagic vesicle pathways.
2023cited by 8position: contributordoi
Endoplasmic reticulum stress promotes HBV production by enhancing use of the autophagosome/multivesicular body axis.
2022cited by 47position: contributordoi
SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19
Nature Communications 2021cited by 245position: middledoi
Hepatitis B virus rigs the cellular metabolome to avoid innate immune recognition
Nature Communications 2021cited by 162position: middledoi
Longitudinal characterization of phenotypic profile of T cells in chronic hepatitis B identifies immune markers associated with HBsAg loss
EBioMedicine 2021cited by 31position: middledoi
mTOR Signaling: The Interface Linking Cellular Metabolism and Hepatitis B Virus Replication.
2021cited by 20position: contributordoi
The impact of hepatitis B surface antigen on natural killer cells in patients with chronic hepatitis B virus infection.
2021cited by 6position: contributordoi
Impaired Cytotoxic CD8 <sup>+</sup> T Cell Response in Elderly COVID-19 Patients
mBio 2020cited by 151position: middledoi
Functional Comparison of Interferon‐α Subtypes Reveals Potent Hepatitis B Virus Suppression by a Concerted Action of Interferon‐α and Interferon‐γ Signaling
Hepatology 2020cited by 81position: middledoi
ANDC: an early warning score to predict mortality risk for patients with Coronavirus Disease 2019
Journal of Translational Medicine 2020cited by 76position: middledoi
AMPK and Akt/mTOR signalling pathways participate in glucose-mediated regulation of hepatitis B virus replication and cellular autophagy.
2020cited by 46position: contributordoi
Erratum for Westmeier et al., “Impaired Cytotoxic CD8 <sup>+</sup> T Cell Response in Elderly COVID-19 Patients”
mBio 2020cited by 31position: middledoi
Discrimination of False Negative Results in RT-PCR Detection of SARS-CoV-2 RNAs in Clinical Specimens by Using an Internal Reference.
2020cited by 25position: contributordoi
Correction to: Discrimination of False Negative Results in RT-PCR Detection of SARS-CoV-2 RNAs in Clinical Specimens by Using an Internal Reference.
2020cited by 3position: contributordoi
Glucosamine promotes hepatitis B virus replication through its dual effects in suppressing autophagic degradation and inhibiting MTORC1 signaling
Autophagy 2019cited by 60position: lastdoi
Treatment of Chronic Hepatitis B Virus Infection Using Small Molecule Modulators of Nucleocapsid Assembly: Recent Advances and Perspectives.
2019cited by 46position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 17 papers (2019–2026)Ulf Dittmer · Essen University Hospital5 papers (2020–2023)Yong Lin · Fujian Medical University5 papers (2016–2023)Kathrin Sutter · Huazhong University of Science and Technology5 papers (2020–2023)Dongliang Yang · Union Hospital5 papers (2012–2023)Jiming Zhang · University of Vermont4 papers (2016–2020)Yulong Ouyang · Nanchang University4 papers (2025–2025)Mirko Trilling · University of Edinburgh4 papers (2020–2023)Guihao Zheng · Nanchang University4 papers (2025–2025)Jia Liu · Shanghai Public Health Clinical Center4 papers (2020–2023)Shi Liu · Dalian Medical University3 papers (2019–2024)Guicai Sun · Nanchang University3 papers (2025–2025)Thekla Kemper · University of Duisburg-Essen3 papers (2016–2019)Shuilin Chen · Nanchang University3 papers (2025–2025)Thorsten Brenner · Essen University Hospital3 papers (2020–2023)Nina Babel · Universitätsklinik Marien Hospital Herne3 papers (2020–2023) · 3 papers (2020–2023)Timm H. Westhoff · Charité - Universitätsmedizin Berlin3 papers (2020–2023) · 3 papers (2020–2023)Gennadiy Zelinskyy · Huazhong University of Science and Technology3 papers (2020–2023)